Table 2:
Null | Truncation | LOF | Transient GOF | Constitutive GOF | |
---|---|---|---|---|---|
WAS disease presentation | Severe WAS | Severe WAS | Mild WAS, may progress to severe | NR | X-linked neutropenia |
Specific phenotypes | Thrombocytopenia, small platelet volume, severe eczema, susceptibility to pyogenic infections, increased incidence of autoimmune disease, and cancer | Thrombocytopenia ± mild eczema | Severe neutropenia, monocytopenia, normal platelet volume, recurrent bacterial infections, myelodysplasia | ||
RAC2 disease presentation | CVID | NR | Neonatal LAD-like | CVID | Neonatal SCID, reticular dysgenesis |
Specific phenotypes | Decreased T cells, decreased B cells, decreased TRECs, recurrent respiratory infections | Neutrophiia, severe bacterial infections, poor wound healing, decreased T cells, decreased TRECs, decreased neutrophil chemotaxis, decreased superoxide to fMLF | Decreased T cells, decreased B cells, decreased TRECs, increased superoxide to fMLF, impaired chemotaxis, increased F-actin | Severe pancytopenia, hypoplastic bone marrow, sepsis, altered mitochondrial function, increased superoxide at baseline, and after PMA |
NR, not reported.